Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Grape polyphenols now shown to have neuroprotective properties

Nov. 26, 1998

Pharmacological profile of PNU-99194A, a D3-preferring dopamine antagonist, reviewed

Nov. 26, 1998

U.S. patent issues for conantokin-G and derivatives

Nov. 26, 1998

Antipsychotic drug dropped from Novartis pipeline

Nov. 25, 1998

Lilly's new glutamate receptor antagonists for pain

Nov. 25, 1998

Central alpha2-adrenoceptor antagonists claimed by Janssen for depression, Parkinson's disease

Nov. 25, 1998

Dopamine D3 receptor antagonists may provide clues about receptor function

Nov. 25, 1998

Tasmar sales suspended in Canada

Nov. 24, 1998

Synapton NDA is nonapprovable, FDA says

Nov. 24, 1998

Substituted heteroaromatic 5-ht1f agonists in development at Lilly as antimigraine agents

Nov. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...